A preparation method of regorafenib
By using a mixed solvent system of ketone organic solvents and dichloromethane and a recrystallization purification step in the preparation of regorafenib, the control problems of impurities G and K were solved, and the industrial production of high-purity regorafenib was realized.
Patent Information
- Application Number
- CN202110293629.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-03-19
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2041-03-19
AI Technical Summary
Existing technologies for preparing regorafenib face challenges in controlling impurities G and K, and the post-processing is complex, making them unsuitable for industrial production.
A mixed solvent system of ketone organic solvents and dichloromethane was used. By controlling the reaction temperature and adding purified water for stirring and crystallization, combined with a recrystallization purification step, the post-processing was simplified and the content of impurities G and K was reduced.
It enables the preparation of high-purity regorafenib, simplifies the post-processing, is more environmentally friendly, and is suitable for industrial production.
Smart Images

Figure FHA0000006383180000011 
Figure GHA0000006383190000011 
Figure GHA0000006383190000012
Abstract
Description
Technical Field
[0001] The present application belongs to the field of drug synthesis. Specifically, the present application relates to a method for preparing regorafenib. Background Art
[0002] Regorafenib: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide is mentioned in WO 05 / 009961, and its specific structure is shown in the following formula I:
[0003]
[0004] The monohydrate of the compound of formula (I) is mentioned in WO 08 / 043446. In addition, salts of the compound of formula (I), such as its hydrochloride, methanesulfonate and phenylsulfonate, are mentioned in WO 05 / 009961 and can be formed by treating the compound of formula (I) with the corresponding acid. The compound of formula (I) is described as being useful for treating hyperproliferative diseases such as cancer, tumors, lymphomas, sarcomas and leukemias.
[0005] WO 05 / 009961 describes a process for preparing compounds of formula (I), which is illustrated in the following scheme:
[0006]
[0007] In the first step, 4-amino-3-fluorophenol is treated with potassium tert-butoxide and a solution of 4-chloro-N-methyl-2-pyridinecarboxamide in N,N-dimethylacetamide is added to form 4-(4-amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamide, which after extraction is finally treated with a solution of (4-chloro-3-(trifluoromethyl)phenyl)isocyanate in toluene to form 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide, which is a compound of formula (I).
[0008] Although the processes disclosed in the prior art are themselves effective for preparing the compound of formula (I), its monohydrate, hydrochloride, methanesulfonate and phenylsulfonate, factors such as purity, product yield, process efficiency, safety and economy are very important for the process of industrial-scale pharmaceutical production. Summary of the invention
[0009] The object of the present invention is to provide a preparation method which can effectively control impurities G and K, has simple post-treatment, avoids the use of organic reagents, is more environmentally friendly, and is suitable for industrial production.
[0010] The specific structures of impurity G and impurity K are as follows:
[0011]
[0012] The present application provides a method for preparing regorafenib, a compound of formula I, comprising the following steps:
[0013]
[0014] A second organic solvent of 4-chloro-3-trifluoromethylphenyl isocyanate is added to a mixed solvent of a first organic solvent and water to prepare a compound of formula II. The mixture is stirred for reaction. Purified water is added and the mixture is stirred for crystallization and washed to obtain a crude target compound.
[0015] Furthermore, the first organic solvent is a ketone organic solvent, preferably acetone, butanone, 2-methyl-3-pentanone or 2-pentanone, and more preferably acetone.
[0016] Further, the second organic solvent is a mixture of a ketone organic solvent and dichloromethane. The ketone organic solvent is preferably acetone, butanone, 2-methyl-3-pentanone or 2-pentanone. Further, acetone is preferred.
[0017] Furthermore, the volume ratio of the ketone solvent to dichloromethane is 3-5:0.5-2, and preferably 4:1.
[0018] Furthermore, the molar mass ratio of the compound of formula II to water is 1:0.5 to 14.5. Further preferably, it is 1:2.
[0019] Furthermore, the molar mass ratio of the compound of formula II to 4-chloro-3-trifluoromethylphenyl isocyanate is 1:1 to 1.2, and preferably 1:1.05.
[0020] Further, in some embodiments of the present invention, the compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled, and a premixed 4-chloro-3-trifluoromethylphenyl isocyanate acetone dichloromethane solution is added dropwise thereto, the reaction is stirred and kept warm, the temperature is controlled, purified water is added, the mixture is stirred for crystallization, filtered, and washed to obtain a crude target compound.
[0021] Further, in some embodiments of the present invention, the compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled at 10 to 20°C, a premixed 4-chloro-3-trifluoromethylisocyanate acetone dichloromethane solution is added dropwise thereto, the mixture is stirred and reacted, the temperature is controlled at 10 to 20°C, purified water is added, the mixture is stirred for crystallization, filtered, and washed to obtain a crude target compound.
[0022] Further, in some embodiments of the present invention, the compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled at 10 to 20°C, a premixed 4-chloro-3-trifluoromethylisocyanate acetone dichloromethane solution is added dropwise thereto, the mixture is stirred and reacted for 1 to 2 hours, the temperature is controlled at 10 to 20°C, purified water is added, the mixture is stirred for crystallization, filtered, the filter cake is washed with an acetone-water mixture, filtered, and dried to obtain a crude target compound.
[0023] Further, in some embodiments of the present invention, the compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled at 10-20°C, a premixed 4-chloro-3-trifluoromethylisocyanate acetone dichloromethane solution is added dropwise thereto, the mixture is stirred and reacted for 1-2 hours, the temperature is controlled at 10-20°C, purified water is added, crystallization is stirred, filtered, the filter cake is washed with a mixture of acetone and water, filtered, and dried to obtain a crude target compound;
[0024] The volume ratio of the ketone solvent to dichloromethane is 4:1; the molar mass ratio of the compound of formula II to water is 1:2; and the molar mass ratio of the compound of formula II to 4-chloro-3-trifluoromethylphenyl isocyanate is 1:1.05.
[0025] Furthermore, in some embodiments of the present invention, a purification step of recrystallizing the crude product of the compound of formula I is also included.
[0026] Further, in some embodiments of the present invention, the crude product of the compound of formula I is subjected to a recrystallization purification step, which is specifically as follows:
[0027] The crude product was dissolved in dimethyl sulfoxide, heated, stirred, acetone and purified water were added, cooled, crystallized, filtered, washed, and dried to obtain the target compound.
[0028] Further, in some embodiments of the present invention, the recrystallization refining step is as follows:
[0029] The crude product was dissolved in dimethyl sulfoxide, heated, stirred, acetone and purified water were added, the temperature was lowered for crystallization, filtered, washed with a mixture of acetone and water and water in turn, and dried to obtain the target compound.
[0030] Further, in some embodiments of the present invention, the recrystallization refining step is as follows:
[0031] The crude product was dissolved in dimethyl sulfoxide, heated, stirred, acetone and purified water were slowly added dropwise, the temperature was lowered for crystallization, filtered, washed with a mixture of acetone and water and water in turn, and dried to obtain the target compound.
[0032] Further, in some embodiments of the present invention, the recrystallization refining step is as follows:
[0033] The crude product was dissolved in dimethyl sulfoxide, heated to 50-60°C, stirred, acetone and purified water were slowly added dropwise, the temperature was gradually reduced to crystallize, filtered, washed with a mixture of acetone and water and water in turn, and dried to obtain the target compound.
[0034] Further, in some embodiments of the present invention, the recrystallization refining step is as follows:
[0035] The crude product was dissolved in dimethyl sulfoxide, heated to 50-60°C, stirred, acetone and purified water were slowly added dropwise, the temperature was controlled at 40-50°C, stirred and crystallized, cooled to 10-20°C, stirred and crystallized, filtered, washed with a mixture of acetone and water and water in turn, and dried to obtain the target compound.
[0036] Through the above process, the contents of impurity K and impurity G in the compound of formula I can be effectively reduced, and the post-treatment is simple, more environmentally friendly, and more suitable for industrial scale-up production. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 HPLC spectrum of the crude product of Example 3;
[0038] Figure 2 HPLC spectrum of the refined product of Example 3. DETAILED DESCRIPTION
[0039] The present invention is further described in detail below in conjunction with the examples. These embodiments are only used to illustrate the present invention, but not to limit the present invention.
[0040] Example 1 HPLC detection method of purity
[0041] Example 1-1
[0042] According to the high performance liquid chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Chapter 0512), octadecylsilane bonded silica gel was used as the filler [Waters Xbridge C18 (4.6mm×150mm, 3.5μm) or a chromatographic column with equivalent performance]; 20mmol / L potassium dihydrogen phosphate buffer-acetonitrile (95:5) was used as mobile phase A, and acetonitrile was used as mobile phase B, and gradient elution was performed according to the table below; the flow rate was 1.0ml per minute; the column temperature was 30°C; the detection wavelength was 232nm; and the injector temperature was 4°C.
[0043]
[0044] The impurity G and impurity K standards were purchased from Guangzhou Junmu Biotechnology Co., Ltd.
[0045] Example 1-2
[0046] According to the high performance liquid chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0512), octadecylsilane bonded silica gel was used as the filler [Kromasil 100-5Phenyl (4.6mm×250mm, 5μm) or a chromatographic column with equivalent performance]; 20mmol / L potassium dihydrogen phosphate buffer-acetonitrile (95:5) was used as mobile phase A, and acetonitrile was used as mobile phase B, and gradient elution was performed according to the table below; the flow rate was 0.9ml per minute; the column temperature was 25°C; the detection wavelength was 230nm; the injector temperature was 4°C; and the injection volume was 5μl.
[0047]
[0048] Example 2 Preparation of Compound of Formula II
[0049] Prepared with reference to the method disclosed in CN103980191A, 4-amino-3-fluorophenol (26.7 g) and 4-methyl-2-pentanone (100 g) were added to a three-necked reaction bottle with a stirrer. After heating to reflux and stirring for 1 hour, water was removed by azeotropic distillation. The excess 4-methyl-2-pentanone was then removed by vacuum distillation and replaced with 1-methyl-2-pyrrolidone (70 g) to prepare a solution of an imine compound containing 3-fluoro-4 ((4-methylpentane-2-ylidene) amino) phenol. A solution of 4-chloro-N-methyl-pyridine-2-carboxamide (34.1 g) in 1-methyl-2-pyrrolidone (70 g) was added to the resulting reaction mixture. The reaction mixture was heated to about 100° C. A solution of 123.2 g of potassium tert-butoxide in tetrahydrofuran (20% w / w) was added dropwise (in about 70 minutes), while tetrahydrofuran was removed by distillation. Thereafter, the reaction mixture was stirred at 100° C. for another 3 hours to complete the reaction. After adjustment to 80° C., 350 ml of toluene, 392 ml of water and 8 g of acetic acid were added. The mixture was stirred at 80° C. for 10 minutes, cooled to 50° C. and induced to crystallize with seeds of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide. After cooling to 0° C., the suspension was stirred for about 30 minutes. The product was filtered out, washed with methanol / water (1:3 v / v, 144 ml) and dried under reduced pressure (30° C., 80 mbar). In this way, 40.7 g (yield 78%) of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide were obtained as brown crystals (HPLC: 97.0%, determined with reference to the analytical method of Example 1-2).
[0050] Example 3
[0051] Under stirring, the compound of formula II (140.5 g) obtained in Example 2 was added to a mixed solvent of acetone / water (534 ml / 19.3 ml first solvent), the temperature was controlled at 10-20° C., and a pre-prepared acetone / dichloromethane solution of 4-chloro-3-trifluoromethylphenylisocyanate (125 g dissolved in 28 ml acetone / 140 ml dichloromethane, second solvent) was dripped into the reaction system, and the reaction was stirred and kept warm for 1-2 h. Purified water (281 ml) was added at a temperature of 10-20°C, and the mixture was stirred and crystallized for 1 hour; the mixture was filtered, and the filter cake was washed and filtered with an acetone / water mixture (46.5 ml / 23.3 ml). The wet product was dried in a vacuum at 60-70°C to obtain 234.4 g of an addition intermediate with a yield of 90.3% (purity: 97.84%, impurity K (0.09%, RT=28.465), impurity G (not detected, RT=8.578), see the analytical method of Example 1-1 for determination). See the attached Figure 1 .
[0052] Dissolve the crude product (220.7g) in dimethyl sulfoxide (663ml), heat to 50-60℃, and stir for 30min. Control the temperature at 50-60℃, and slowly drop acetone (439ml) and purified water (331ml) into the reaction system. After the dropwise addition, slowly cool down to precipitate solid, control the temperature at 40-50℃, stir and crystallize for 1h. Cool down to 10-20℃, and stir and crystallize for 2h. The filter cake was filtered, and the filter cake was rinsed and filtered with a mixture of acetone / water (110 ml / 110 ml) and purified water (441 ml) in turn. The filter cake was dried in vacuo at 50-60 ° C to obtain 200.5 g of regorafenib with a yield of 90.8% (purity 99.70%, maximum single impurity 0.06%, impurity G (not detected, RT = 8.578 min), impurity K (0.05%, RT = 28.475 min), as determined by the analytical method of Example 1-1, see the attached Figure 2 .
[0053] Example 4 Investigating the effects of different solvents on the reaction
[0054] Example 4-1
[0055] The compound of formula II (10 g) obtained in Example 2 was added to acetone (38 ml of the first solvent), the temperature was controlled at 10-20°C, and the pre-prepared 4-chloro-3-trifluoromethylphenylisocyanate acetone / dichloromethane solution (8.9 g dissolved in 2 ml of acetone / 10 ml of dichloromethane, the second solvent) was dripped into the reaction system, and the mixture was stirred and reacted for 1-2 hours. Purified water (20 ml) was added at a temperature of 10-20°C, and the mixture was stirred and crystallized for 1 hour; filtered, and the wet product was vacuum dried at 60-70°C to obtain the product.
[0056] The preparation methods of Examples 4-2 to 4-7 were prepared by referring to the method of Example 4-1. The specific results are shown in Table 1.
[0057] Table 1 Summary of reaction results of different solvents
[0058]
[0059] ND means not determined.
[0060] The above results show that in acetone, the first solvent system of acetone / water, and the second solvent system of acetone and dichloromethane, a high yield and high purity product can be prepared.
[0061] Example 5 Investigating the effects of different feed volume ratios on the reaction
[0062] Example 5-1
[0063] The compound of formula II (10 g) obtained in Example 2 was added to acetone (38 ml of the first solvent), the temperature was controlled at 10-20°C, and the pre-prepared 4-chloro-3-trifluoromethylphenylisocyanate acetone / dichloromethane solution (8.9 g dissolved in 2 ml of acetone / 10 ml of dichloromethane, the second solvent) was dripped into the reaction system, and the mixture was stirred and reacted for 1-2 hours. Purified water (20 ml) was added at a temperature of 10-20°C, and the mixture was stirred and crystallized for 1 hour; filtered, and the wet product was vacuum dried at 60-70°C to obtain the product.
[0064] The preparation of Examples 5-2 to 5-4 was carried out by referring to the method of Example 5-1.
[0065] Table 2 Summary of reaction results of different solvent ratios
[0066]
[0067] Example 6
[0068] Example 6-1
[0069] The compound of formula II (10 g) obtained in Example 2 was added to acetone (38 ml first solvent), the temperature was controlled at 10-20°C, and the pre-prepared 4-chloro-3-trifluoromethylphenylisocyanate acetone / dichloromethane solution (8.9 g dissolved in 2 ml acetone / 10 ml dichloromethane, the second solvent) was dripped into the reaction system, and the mixture was stirred and reacted for 1-2 hours. Purified water (20 ml) was added at a temperature of 10-20°C, and the mixture was stirred and crystallized for 1 hour; filtered, and the wet product was vacuum dried at 60-70°C to obtain the product.
[0070] The preparation methods of Examples 6-2 and 6-3 were prepared with reference to that of 6-1. The specific results are shown in the following table.
[0071] Table 3 Summary of reaction results at different dosages
[0072]
[0073]
[0074] Example 7 Comparison of the effects of different water addition amounts on the entire reaction system
[0075] Example 7-3
[0076] The obtained compound of formula II (10 g) is added to a mixed solvent of acetone (38 ml first solvent) and water (1.4 ml), and the temperature is controlled at 10-20°C. The pre-prepared acetone / dichloromethane solution of 4-chloro-3-trifluoromethylphenylisocyanate (8.9 g dissolved in 2 ml acetone / 10 ml dichloromethane, the second solvent) is dripped into the reaction system, and the mixture is stirred and reacted for 1-2 hours. Purified water (20 ml) is added at a temperature of 10-20°C, and the mixture is stirred and crystallized for 1 hour; the mixture is filtered, and the wet product is vacuum dried at 60-70°C to obtain the product.
[0077] The preparation of Examples 7-1, 7-2, 7-4 to 7-6 refers to the method of 7-3, and the specific results are shown in Table 4.
[0078] Table 4 Summary of reaction results at different water contents
[0079]
Claims
1. A method for preparing regorafenib, a compound of formula I, comprising the following steps: The method is characterized in that: a second organic solvent of 4-chloro-3-trifluoromethylphenyl isocyanate is added to a mixed solvent of a first organic solvent and water, the reaction is stirred, purified water is added, the mixture is stirred for crystallization, and the mixture is washed to obtain a crude target compound, wherein the first organic solvent is acetone, the second organic solvent is a mixture of acetone and dichloromethane, the molar mass ratio of the compound of formula II to water is 1:2, and the volume ratio of the total volume of acetone in the first organic solvent and the second organic solvent to dichloromethane is 4:
1.
2. The method for preparing a compound of formula (I) according to claim 1, characterized in that: The molar mass ratio of the compound of formula II to 4-chloro-3-trifluoromethylphenyl isocyanate is 1:1 to 1.
2.
3. The method for preparing a compound of formula (I) according to claim 2, characterized in that: The molar mass ratio of the compound of formula II to 4-chloro-3-trifluoromethylphenyl isocyanate is 1:1.
05.
4. The method for preparing a compound of formula (I) according to claim 1, characterized in that: The compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled, and a premixed 4-chloro-3-trifluoromethylphenylisocyanate acetone dichloromethane solution is added dropwise thereto, the reaction is stirred and kept warm, the temperature is controlled, purified water is added, the mixture is stirred for crystallization, filtered, and washed to obtain a crude target compound.
5. A method for preparing a compound of formula I according to claim 1, characterized in that: Add the compound of formula II to a mixed solvent of acetone and water, control the temperature at 10-20°C, add dropwise a premixed 4-chloro-3-trifluoromethylphenylisocyanate acetone dichloromethane solution thereto, stir and react while keeping the temperature at 10-20°C, add purified water, stir and crystallize, filter and wash to obtain a crude target compound.
6. A method for preparing a compound of formula I according to claim 1, characterized in that: Add the compound of formula II to a mixed solvent of acetone and water, control the temperature at 10-20°C, add dropwise a premixed 4-chloro-3-trifluoromethylphenylisocyanate acetone dichloromethane solution thereto, keep warm and stir to react for 1-2h, control the temperature at 10-20°C, add purified water, stir to crystallize, filter, wash the filter cake with a mixture of acetone and water, filter, and dry to obtain a crude target compound.
7. A method for preparing a compound of formula I according to claim 1, characterized in that: The compound of formula II is added to a mixed solvent of acetone and water, the temperature is controlled at 10-20°C, and a premixed acetone-dichloromethane solution of 4-chloro-3-trifluoromethylphenylisocyanate is added dropwise thereto. The mixture is stirred and reacted for 1-2 hours. The temperature is controlled at 10-20°C, purified water is added, stirred for crystallization, filtered, the filter cake is washed with a mixture of acetone and water, filtered, and dried to obtain a crude target compound; the molar mass ratio of the compound of formula II to 4-chloro-3-trifluoromethylphenylisocyanate is 1:1.
05.
8. The method for preparing a compound of formula I according to claim 1, further comprising a purification step of recrystallizing the crude product of the compound of formula I.
9. The method for preparing a compound of formula I according to claim 8, wherein the recrystallization purification step is specifically: dissolving the crude product in dimethyl sulfoxide, heating, stirring, adding acetone and purified water, cooling and crystallizing, filtering, washing, and drying to obtain the target compound.
10. The method for preparing a compound of formula I according to claim 8, wherein the recrystallization purification step is specifically: dissolving the crude product in dimethyl sulfoxide, heating, stirring, adding acetone and purified water, cooling for crystallization, filtering, washing with a mixture of acetone and water and water in sequence, and drying to obtain the target compound.
11. A method for preparing a compound of formula I according to claim 8, wherein the recrystallization and purification step comprises: dissolving the crude product in dimethyl sulfoxide, heating, stirring, slowly adding acetone and purified water dropwise, cooling for crystallization, filtering, washing with a mixture of acetone and water and water in sequence, and drying to obtain the target compound.
12. The method for preparing a compound of formula I according to claim 8, wherein the recrystallization refining step comprises: dissolving the crude product in dimethyl sulfoxide, heating to 50-60° C., stirring, slowly adding acetone and purified water dropwise, gradually cooling and crystallizing, filtering, washing with a mixture of acetone and water and water in sequence, and drying to obtain the target compound.
13. The method for preparing a compound of formula I according to claim 8, wherein the recrystallization refining step comprises: dissolving the crude product in dimethyl sulfoxide, heating to 50-60° C., stirring, slowly adding acetone and purified water dropwise, controlling the temperature at 40-50° C., stirring and crystallizing, cooling to 10-20° C., stirring and crystallizing, filtering, washing with a mixture of acetone and water and water in sequence, and drying to obtain the target compound.
Citation Information
Patent Citations
Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate
CN103980191A
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
WO2005009961A2
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
WO2008043446A1
Process for the preparation of regorafenib and its crystalline forms
US20170204062A1
